Mobile low-dose CT lung cancer screening program
Official title: Lyon Initiative for the Mobile Demedicalized Initiation of Lung Cancer Screening
Run by Hospices Civils de Lyon · NCT07015151 · Data updated 2026-11-12
This project will try using a CT-equipped mobile unit versus a hospital screening unit to screen people aged 50–74 with a heavy smoking history.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 75 Years |
| Sex | All |
| Enrollment | 4312 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 2 sites (Pierre-Bénite and 1 other locations) |
| Status | Recruiting |
| Started | June 12, 2025 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT07015151 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 50–74 who are current smokers or who quit within the past 15 years with a substantial smoking history (roughly ≥20 pack-years or equivalent by specified conversion), covered by French social security, and able to provide informed consent.
✕Probably not a fit
People outside the age or smoking-history eligibility criteria or those with severe comorbidities that preclude LDCT or follow-up care are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
MobILYAD compares a demedicalized CT-equipped mobile van staffed by trained nurses with a conventional hospital-based screening pathway at Hôpital Lyon Sud to determine which better reaches socially disadvantaged populations. Eligible participants receive low-dose chest CT, spirometry, a cardiovascular risk check, smoking cessation support, and optional biospecimen collection. The project uses a proactive 'reach-out' strategy informed by mobile screening models from other countries and by mobile mammography experience in France. Results will inform the national pilot program (IMPULSION) planned for 2025 by measuring participation, detection rates, and operational feasibility.
Why it matters
Potential benefit: If successful, the mobile approach could increase screening uptake among underserved populations and help detect lung cancers earlier in high-risk smokers.
How similar studies have gone: Mobile outreach screening approaches have shown effectiveness in the UK, Brazil, and the USA and mobile mammography has been used in France, supporting the rationale though mobile LDCT in France is being newly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria \* : * Persons aged over 50 and under 75 (74 years of age or older). * Active smokers or former smokers who quit less than 15 years ago. * Persons whose consumption is estimated at 20 packs/year or more, down to ≥15 cigarettes/day for a duration of consumption of ≥25 years and up to ≥10 cigarettes/day for ≥30 years, which takes into account the predominance of duration of consumption over quantity consumed in the risk of lung cancer. A pack-year corresponds to the consumption of one pack of 20 manufactured cigarettes per day for one year. A multiplier coefficient will be taken into account depending on the mode of consumption: Rolled cigarettes: 2; Cigarillos: 3; Cigars: 4; Pipes: 2.5; Hookahs: 25. * Persons affiliated with social security. - Person having signed their consent to participate in the study after having received full information about it, including the risks associated with participation. * Exclusion Criteria \* : * Individuals with severe comorbidities contraindicating lung cancer investigations and/or treatment (including surgery or stereotactic radiotherapy); * Individuals with impaired general condition (PS 2 and above); * Individuals with dyspnea at rest (mMRC4); * Individuals with a history of cancer undergoing active surveillance by chest computed tomography (CT or PET scan); personal history of lung cancer (lifetime); * Individuals with symptoms suggestive of lung cancer (hemoptysis, unexplained weight loss, recent onset or change in respiratory symptoms, etc.); * Individuals refusing to participate in the study * Individuals withdrawing their consent.
Where it's running
-
" Centre de dépistage mobile " - Hôpital Lyon Sud
Pierre-Bénite, France Recruiting -
Service de Pneumologie " Centre de dépistage non mobile " - Hôpital Lyon Sud
Pierre-Bénite, France Recruiting
Study contacts
- Study coordinator: Sébastien COURAUD, Pr
- Email: sebastien.couraud@chu-lyon.fr
- Phone: 04 78 86 44 01
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood viscosity in ARDS: a look at how thick the blood is
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
-
Virus interactions in hospitalized patients during winter seasons in Lyon
This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.
-
Surgical Use of Efanoctocog alfa in Hemophilia A Patients
This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Compare Trans-Stomal Bladder Lithotripsy Methods in Continent Catheterizable Urinary Reservoirs
This study looks at different ways to break up bladder stones in people with continent catheterizable urinary diversions to see which method works best when the normal route isn’t available.
-
French version validation of the New Mobility Score for older adults after hip fracture
This study tests whether the French version of the New Mobility Score accurately measures mobility in French patients aged 75 and older after hip fracture.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.